In an exciting development for the future of biopharmaceuticals, Elektrofi has successfully raised $112 million in its latest funding round, a testament to the growing confidence in its innovative platform. Based in Boston, Elektrofi is at the forefront of biopharmaceutical formulation technology, committed to revolutionizing the way biologic therapies are delivered to patients. With its proprietary Hypercon™ technology, Elektrofi addresses the critical limitations of traditional intravenous delivery by enabling patients to self-administer life-changing monoclonal antibodies and other large molecule drugs via convenient subcutaneous injections right from their homes. This patient-centric approach not only enhances the quality of care but also improves adherence to treatment regimens, paving the way for a healthier world. The newly acquired funding will primarily be allocated towards advancing the development and commercialization of its transformative therapies, as well as expanding partnerships with strategic collaborators. With its significant capital infusion, Elektrofi is well-positioned to further innovate within the biopharmaceutical landscape, ensuring that patients have the flexibility and control they deserve in their healthcare journeys. As Elektrofi continues to push the boundaries of biopharmaceutical technology, it remains committed to formulating the future of biologics, enhancing life for countless individuals in the process. Visit www.Elektrofi.com to learn more about our mission and breakthroughs.
Elektrofi Secures $112 Million in Funding to Revolutionize Biologic Therapy Delivery
Recently funded · $112.0MBiotechnology
Get the full Elektrofi company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
